» Articles » PMID: 15448689

Induction of T Helper Type 1-like Regulatory Cells That Express Foxp3 and Protect Against Airway Hyper-reactivity

Overview
Journal Nat Immunol
Date 2004 Sep 28
PMID 15448689
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

The range of regulatory T cell (T(R) cell) types that control immune responses is poorly understood. We describe here a population of T(R) cells that developed in vivo from naive CD4(+)CD25(-) T cells during a T helper type 1 (T(H)1)-polarized response, distinct from CD25(+) T(R) cells. These antigen-specific T(R) cells were induced by CD8alpha(+) DCs, produced both interleukin 10 and interferon-gamma, and potently inhibited the development of airway hyper-reactivity. These T(R) cells expressed the transcription factors Foxp3 and T-bet, indicating that these T(R) cells are related to T(H)1 cells. Thus, adaptive T(R) cells are heterogeneous and comprise T(H)1-like T(R) cells as well as previously described T(H)2-like T(R) cells, which express Foxp3 and are induced during the development of respiratory tolerance by CD8alpha(-) DCs.

Citing Articles

The BCG vaccine, advantages, and disadvantages of introducing new generation vaccines against .

Mahdizade Ari M, Beig M, Sholeh M, Khoshmirsafa M Clin Exp Vaccine Res. 2024; 13(3):184-201.

PMID: 39144128 PMC: 11319110. DOI: 10.7774/cevr.2024.13.3.184.


Immunomodulatory Effects of Subacute Inhalation Exposure to Copper Oxide Nanoparticles in House Dust Mite-Induced Asthma.

Areecheewakul S, Adamcakova-Dodd A, Zacharias Z, Jing X, Meyerholz D, Legge K ACS Nano. 2023; 17(15):14586-14603.

PMID: 37463491 PMC: 10416562. DOI: 10.1021/acsnano.3c01668.


Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis.

Straeten F, Zhu J, Borsch A, Zhang B, Li K, Lu I J Neuroinflammation. 2022; 19(1):306.

PMID: 36536441 PMC: 9764586. DOI: 10.1186/s12974-022-02667-9.


Immunogenicity of a novel anti-allergic vaccine based on house dust mite purified allergens and a combination adjuvant in a murine prophylactic model.

Ramirez W, Torralba D, Bourg V, Lastre M, Perez O, Jacquet A Front Allergy. 2022; 3:1040076.

PMID: 36479436 PMC: 9720566. DOI: 10.3389/falgy.2022.1040076.


Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment.

Klier J, Fuchs S, Winter G, Gehlen H Animals (Basel). 2022; 12(16).

PMID: 36009677 PMC: 9405334. DOI: 10.3390/ani12162087.